NRC
NRC HEALTH
Key Financials
Net Income
$30.0M
↑ 31.0%
Revenue
$137.4M
↓ 4.0%
Operating Income
$22.6M
↓ 35.8%
Cash & Equivalents
$4.1M
↓ 2.2%
Total Liabilities
$120.9M
↑ 19.4%
Total Assets
$134.9M
↑ 1.8%
EPS (Diluted)
$50.00
↑ 4707.7%
Shareholders' Equity
$14.0M
↓ 55.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/29/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| SCHEDULE 13D/A | 6/12/2026 | View on SEC |
| 424B7 | 5/13/2026 | View on SEC |
| ARS | 5/8/2026 | View on SEC |
| DEFA14A | 5/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NRC |
| Company Name | NRC HEALTH |
| CIK | 70487 |
| Sector | Services-Commercial Physical & Biological Research |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 4024752525 |